Human Metabolome Technologies Profit Margin

Human Metabolome Technologies's profit margin stands at 14.09% as of June 2026. That compares with 17.61% in the prior-year period — down 20.0% year over year. That is above the Healthcare sector average of 9.48%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Human Metabolome Technologies reported 14.09% in profit margin versus 17.61% a year earlier — a 20.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Human Metabolome Technologies sits higher the Healthcare benchmark (9.48%) with a profit margin of 14.09%. That is roughly 48.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 14.09% for Human Metabolome Technologies means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Human Metabolome Technologies's profit margin evolved across reporting periods, while the comparison chart places 6090.T next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.